Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
ORBIMED ADVISORS LLC - 25 Jul 2025 SCHEDULE 13D/A Report for ImageneBio, Inc. COMMON STOCK (IKNA)
- Filing manager
- ORBIMED ADVISORS LLC
- Reporting owner
- ORBIMED ADVISORS LLC
- Security
- ImageneBio, Inc. COMMON STOCK
- Beneficially owned shares
- 773,754 shares
- Large-stake signal
-
Ownership
6.9%Beneficial ownership of this reported class.
Shares
773,754 sharesShares beneficially owned as disclosed.
Event date
25 Jul 2025Date tied to the ownership event or amendment.
Accepted by SEC
30 Jul 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 6.9%
- Symbol
- IKNA
- Shares outstanding
- 11,181,416 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 30 Jul 2025, 21:28:19 UTC
- Event date
- 25 Jul 2025
- Prior SEC filing
- 18 Jun 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
ORBIMED ADVISORS LLC disclosed 6.9% ownership in ImageneBio, Inc. COMMON STOCK (IKNA) on 25 Jul 2025.
Key facts
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for ImageneBio, Inc. COMMON STOCK (IKNA).
- Disclosed ownership: 6.9%.
- Date of event: 25 Jul 2025.
Change
- Previous schedule filing date: 18 Jun 2025.
- Current filing was accepted on 30 Jul 2025, 21:28.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (4)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 6.9% | 773,754 | 0 | 773,754 | /s/ Carl L. Gordon | Carl L. Gordon, Member | 0001055951 |
| ORBIMED CAPITAL GP VI LLC | 6.7% | 753,063 | 0 | 753,063 | /s/ Carl L. Gordon | Carl L. Gordon, Member of OrbiMed Advisors LLC | 0001682115 |
| OrbiMed Genesis GP LLC | 0.19% | 20,691 | 0 | 20,691 | /s/ Carl L. Gordon | Carl L. Gordon, Member of OrbiMed Advisors LLC | 0001808744 |
| ORBIMED CAPITAL LLC | 1.2% | 135,516 | 135,516 | 0 | /s/ Carl L. Gordon | Carl L. Gordon, Member | 0001157524 |
CIK / CUSIP context first